In All Facilities Letter (AFL) 19-28, the California Department of Public Health has announced a nationwide shortage of the tuberculin skin test antigen Aplisol, as well as new guidelines from the Centers for Disease Control and Prevention (CDC) for tuberculosis screening of health care personnel. The notice also reminds providers that an approved program flexibility is required if a facility deviates from tuberculosis screening requirements.
This content is restricted to members.
